
Dazzler AQ 75mg Injection
Marketer
American Biocare
Salt Composition
Diclofenac (75mg)
Overview Dazzler AQ 75mg Injection
Lumiflex 75mg Injection provides pain relief. Indicated for managing pain, inflammation, rigidity, and arthritic discomfort in conditions such as rheumatoid and osteoarthritis, and acute musculoskeletal trauma, it's administered when oral intake is infeasible. This injection must be given by a qualified medical practitioner; self-administration is strictly prohibited. Patients with a history of cardiovascular events (heart disease or stroke) should inform their physician. Report any injection site reactions (pain, swelling, redness) to your doctor immediately. Common adverse effects include nausea, vomiting, headache, and injection site responses. For extended therapy, regular monitoring of renal and hepatic function, along with blood counts, is typical. Prolonged use carries a risk of serious complications, including gastrointestinal bleeding and renal dysfunction.
Uses of Dazzler AQ 75mg Injection
Analgesia
Major Benefits of Dazzler AQ 75mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Dazzler AQ 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Dazzler AQ 75mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Dazzler AQ 75mg Injection works:
Dazzler AQ 75mg Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated symptoms of redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Dazzler AQ 75mg Injection requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Dazzler AQ 75mg Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Administration of Dazzler AQ 75mg Injection while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Dazzler AQ 75mg Injection may impair driving ability due to potential adverse reactions.
KidneyCAUTION
The use of Dazzler AQ 75mg Injection requires careful consideration in individuals with impaired kidney function. A modified dosage of Dazzler AQ 75mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
The use of Dazzler AQ 75mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Dazzler AQ 75mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Dazzler AQ 75mg Injection :
Omit a Dazzler AQ 75mg Injection dose? Seek your physician's advice.
Facts to Know About Dazzler AQ 75mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylacetic Acid Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
